KR20230175241A - 형태 전환 나노구조체 - Google Patents
형태 전환 나노구조체 Download PDFInfo
- Publication number
- KR20230175241A KR20230175241A KR1020237039385A KR20237039385A KR20230175241A KR 20230175241 A KR20230175241 A KR 20230175241A KR 1020237039385 A KR1020237039385 A KR 1020237039385A KR 20237039385 A KR20237039385 A KR 20237039385A KR 20230175241 A KR20230175241 A KR 20230175241A
- Authority
- KR
- South Korea
- Prior art keywords
- nanostructure
- coupling
- molecule
- entity
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/35—Valency
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21169934.3A EP4079330A1 (en) | 2021-04-22 | 2021-04-22 | Conformation switching nanostructures |
| EP21169934.3 | 2021-04-22 | ||
| PCT/EP2022/060737 WO2022223802A1 (en) | 2021-04-22 | 2022-04-22 | Conformation switching nanostructures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20230175241A true KR20230175241A (ko) | 2023-12-29 |
Family
ID=75659780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237039385A Pending KR20230175241A (ko) | 2021-04-22 | 2022-04-22 | 형태 전환 나노구조체 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240199763A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP4079330A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024515346A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230175241A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117222437A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022223802A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4399528A1 (en) | 2021-09-09 | 2024-07-17 | Nautilus Subsidiary, Inc. | Characterization and localization of protein modifications |
| EP4764494A1 (en) * | 2024-12-20 | 2026-06-24 | Plectonic Biotech GmbH | Conjugates for analyte detection and quantification |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020254684A1 (en) * | 2019-06-21 | 2020-12-24 | Tilibit Nanosystems Gmbh | Conditionally switchable nanostructure |
-
2021
- 2021-04-22 EP EP21169934.3A patent/EP4079330A1/en not_active Withdrawn
-
2022
- 2022-04-22 US US18/287,269 patent/US20240199763A1/en active Pending
- 2022-04-22 EP EP22724742.6A patent/EP4326342A1/en active Pending
- 2022-04-22 JP JP2023564438A patent/JP2024515346A/ja active Pending
- 2022-04-22 KR KR1020237039385A patent/KR20230175241A/ko active Pending
- 2022-04-22 WO PCT/EP2022/060737 patent/WO2022223802A1/en not_active Ceased
- 2022-04-22 CN CN202280030065.3A patent/CN117222437A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240199763A1 (en) | 2024-06-20 |
| EP4326342A1 (en) | 2024-02-28 |
| CN117222437A (zh) | 2023-12-12 |
| JP2024515346A (ja) | 2024-04-09 |
| WO2022223802A1 (en) | 2022-10-27 |
| EP4079330A1 (en) | 2022-10-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Roxo et al. | G-quadruplex-forming aptamers—characteristics, applications, and perspectives | |
| Jain et al. | Comparison of avidin, neutravidin, and streptavidin as nanocarriers for efficient siRNA delivery | |
| Edwardson et al. | Virus-inspired function in engineered protein cages | |
| Burckhardt et al. | Virus movements on the plasma membrane support infection and transmission between cells | |
| Li et al. | Aptamer displacement reaction from live-cell surfaces and its applications | |
| Smith et al. | Nucleic acid nanostructures for biomedical applications | |
| US9297013B2 (en) | pRNA multivalent junction domain for use in stable multivalent RNA nanoparticles | |
| Kamiya et al. | Pharmacokinetic and pharmacodynamic considerations in gene therapy | |
| Chen et al. | Framework nucleic acid nanomaterials for central nervous system therapies: design for barrier penetration, targeted delivery, cellular uptake, and endosomal escape | |
| Backlund et al. | Protein and antibody delivery into difficult-to-transfect cells by polymeric peptide mimics | |
| JP2014533953A (ja) | 治療用rnaスイッチ組成物及び使用方法 | |
| US10155946B2 (en) | Particle-nucleic acid conjugates and therapeutic uses related thereto | |
| Kim et al. | Molecular Complementarity of Proteomimetic Materials for Target‐Specific Recognition and Recognition‐Mediated Complex Functions | |
| Andrea et al. | Adsorption of oligo-DNA on magnesium aluminum-layered double-hydroxide nanoparticle surfaces: Mechanistic implication in gene delivery | |
| Shi et al. | Virus mimetic framework DNA as a non-LNP gene carrier for modulated cell endocytosis and apoptosis | |
| Liu et al. | Factors determining the efficacy of nuclear delivery of antisense oligonucleotides by gold nanoparticles | |
| Colombo et al. | Complexity in the therapeutic delivery of RNAi medicines: an analytical challenge | |
| US20190117572A1 (en) | Microfluidic-formulated leukosome compositions and fabrication methods therefor | |
| US20240199763A1 (en) | Conformation switching nanostructures | |
| Menon et al. | Designer, Programmable DNA‐peptide hybrid materials with emergent properties to probe and modulate biological systems | |
| Khorenko et al. | Foscarnet-type inorganic-organic hybrid nanoparticles for effective antiviral therapy | |
| Wu et al. | Precise construction of DNA origami‐based materials for functional regulation on biological interface | |
| Egorova et al. | Anti-Angiogenic RNAi-Based Treatment of Endometriosis in a Rat Model Using CXCR4-Targeted Peptide Nanoparticles | |
| Ma et al. | AIDS treatment with novel anti-HIV compounds improved by nanotechnology | |
| Levina et al. | TiO2∼ DNA nanocomposites as efficient site-specific antiviral agents against influenza A virus in cell culture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20231115 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20250314 Comment text: Request for Examination of Application |